OncologyTube Professional - Patients Click Here
275,366 video views
VJOncology: Videos
02:39
A large proportion of gynecological tumors are classed as rare tumors because of their variable morphologies and pathologies. We interviewed Marcia Hall, MBBS, PhD, FRCP, of the East and North Hertfordshire NHS Trust, Hertfordshire, UK, about these rare tumors at the UK Oncology Forum (OF) 2018, hel...
by:VJOncology | 21 views
01:20
Collaboration for Oncology Data in Europe (CODE) is an alliance that brings together patient associations, charities and treatment centers in Europe. The main aim of CODE is to help build a pan-European oncology data network to facilitate data sharing. Here, Ashley Woolmore, Initiative Lead for CODE...
by:VJOncology | 47 views
03:52
Marianne Nicolson, MD, FRCP, BSc, MBChB, of NHS Grampian, Aberdeen, UK, gives an overview of a session discussing lung cancer that she chaired at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. Prof. Nicolson gives a summary of the updates from the session, referencing a number of speakers, including Mariam Jamal-Hanjani, who spoke about he...
by:VJOncology | 37 views
01:05
The integration of scientific research into clinical practice is one of the many challenges healthcare professionals face. Here, Mariam Jamal-Hanj, BSc, MBBS, PhD, of University College London, London, UK, discusses the implementation of longitudinal studies, such as TRACERx (NCT01888601) and PEACE (NCT03004755), into the real world in the context ...
by:VJOncology | 29 views
01:02
Vicky Coyle, MD, of Queen's University Belfast, Belfast, UK, spoke to us at the UK Oncology Forum (OF) 2018, held in Liverpool, UK, about the benefits of physical activity in the adjuvant setting. She discusses her current trial exploring the role of exercise as a treatment after standard chemotherapy and surgery for stage II and III colon cancer. ...
by:VJOncology | 39 views
02:19
Mariam Jamal-Hanj, BSc, MBBS, PhD, of University College London, London, UK, discusses her talk regarding intra-tumor heterogeneity within lung cancer at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. She highlights the significance of longitudinal studies, such as TRACERx (NCT01888601) and...
by:VJOncology | 33 views
02:01
Aspirin has been suggested as a preventative measure for several cancer types, in particular colorectal cancer, as Vicky Coyle, MD, of Queen's University Belfast, Belfast, UK, explains at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. She describes a current trial that aims to identify the ...
by:VJOncology | 19 views
01:39
Kai-Keen Shiu, MRCP, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, speaks to us about future directions for the treatment of rectal cancer at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. He discusses the possibility of a new treatment strategy using total neoadjuvant therapy with reduced oxaliplatin dosage...
by:VJOncology | 11 views
01:39
Tumor suppressor gene TP53 is associated with aggressive disease activity when inactivated in a variety of tumor types, including multiple myeloma (MM). Speaking from the British Society for Haematology (BSH) 2018 Annual Meeting in Liverpool, UK, Martin Kaiser, MD, RWTH, of the Royal Marsden NHS Fou...
by:VJOncology | 21 views
01:04
In this interview with Andrew Armstrong, MD, of Duke University, Durham, NC, speaking from the 2018 American Society of Oncology (ASCO) Annual Meeting, held in Chicago, IL, discusses how to best catch and diagnosis osteomimicry in metastatic castration-resi​stant prostate cancer (mCRPC). Dr Armstrong...
by:VJOncology | 32 views
dsfsd